Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder

NCT00384033 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

638

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: Desvenlafaxine Succinate Sustained-Release (DVS SR)
DRUG: Desvenlafaxine Succinate Sustained-Release (DVS SR)
DRUG: Placebo
DRUG: Duloxetine 60 mg/day

Sponsor

Pfizer